GSI 250 (Viread 250 mg)
Generic Name: tenofovir
Pill with imprint GSI 250 is White, Capsule-shape and has been identified as Viread 250 mg. It is supplied by Gilead Sciences, Inc..
Viread is used in the treatment of hepatitis b; occupational exposure; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 250
Viread
- Generic Name
- tenofovir
- Imprint
- GSI 250
- Strength
- 250 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-0406
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
lactose monohydrate,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
triacetin,
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
More about Viread (tenofovir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 13 Reviews
- Generic Availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- FDA Alerts (1)
Consumer resources
- Patient Information
- Viread (Advanced Reading)
- Viread (Tenofovir Disoproxil Fumarate Oral Powder)
- Viread (Tenofovir Disoproxil Fumarate Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.